DUMUSC, A.; NG, W.-F.; JAMES, K.; GRIFFITHS, B.; PRICE, E.; PEASE, C. T.; EMERY, P.; LANYON, P.; JONES, A.; BOMBARDIERI, M.; SUTCLIFFE, N.; PITZALIS, C.; GUPTA, M.; MCLAREN, J.; COOPER, A.; GILES, I.; ISENBERG, D.; SARAVANAN, V.; COADY, D.; DASGUPTA, B.; MCHUGH, N.; YOUNG-MIN, S.; MOOTS, R. J.; GENDI, N.; AKIL, M.; BARONE, F.; FISHER, B. A.; RAUZ, S.; RICHARDS, A.; BOWMAN, S. J.; ON BEHALF OF THE UK PRIMARY SJÖGREN’S SYNDROME REGISTRY. Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry. Swiss Medical Weekly, [S. l.], v. 148, n. 0506, p. w14588, 2018. DOI: 10.4414/smw.2018.14588. Disponível em: https://smw.ch/index.php/smw/article/view/2444. Acesso em: 27 nov. 2024.